Literature DB >> 9344196

Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia.

S C Baer1, L Casaubon, M Younes.   

Abstract

BACKGROUND: The increased glucose uptake seen in cancer cells correlates with the expression of human erythrocyte glucose transporter (Glut1) protein in certain human malignancies.
OBJECTIVE: Our purpose was to determine Glut1 expression in cutaneous neoplasms.
METHODS: A polyclonal anti-Glut1 antibody (MYM) and a standard ABC immunoperoxidase technique were used to determine Glut1 expression in invasive squamous cell carcinomas (SCCs), SCC in situ, basal cell carcinomas (BCCs), melanomas, actinic keratoses (AKs), seborrheic keratoses, common acquired nevi, and scars with regenerative epidermal hyperplasia.
RESULTS: All of the cases of SCC in situ, 14 of 15 (93%) of the SCC, and 13 of 15 AKs (87%) showed intense membranous staining for Glut1. Glut1 staining was present in the epidermis of 8 of 15 scars (53%) but was not detected in any BCC, even in areas of focal keratinization and squamous metaplasia. Glut1 reactivity was absent in the melanomas and seborrheic keratoses.
CONCLUSION: Glut1 expression in a cutaneous lesion strongly suggests a proliferative lesion of the squamous cell type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344196     DOI: 10.1016/s0190-9622(97)70174-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  14 in total

1.  Overexpression of tumor suppressor protein OSCP1/NOR1 induces ER stress and apoptosis during development of Drosophila melanogaster.

Authors:  Nguyen Tho Huu; Hideki Yoshida; Masamitsu Yamaguchi
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 2.  Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Authors:  Eiji Furuta; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2010-02-01

3.  The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.

Authors:  Céline Pinheiro; Vera Miranda-Gonçalves; Adhemar Longatto-Filho; Anna L S A Vicente; Gustavo N Berardinelli; Cristovam Scapulatempo-Neto; Ricardo F A Costa; Cristiano R Viana; Rui M Reis; Fátima Baltazar; Vinicius L Vazquez
Journal:  Cell Cycle       Date:  2016-04-22       Impact factor: 4.534

4.  Development of a novel class of glucose transporter inhibitors.

Authors:  Dasheng Wang; Po-Chen Chu; Chia-Ning Yang; Ribai Yan; Yu-Chung Chuang; Samuel K Kulp; Ching-Shih Chen
Journal:  J Med Chem       Date:  2012-04-10       Impact factor: 7.446

Review 5.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

6.  GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker.

Authors:  Kátia C Carvalho; Isabela W Cunha; Rafael M Rocha; Fernanda R Ayala; Mariana M Cajaíba; Maria D Begnami; Rafael S Vilela; Geise R Paiva; Rodrigo G Andrade; Fernando A Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Evaluation of Hypoxia Inducible Factor-1α and Glucose Transporter-1 Expression in Non Melanoma Skin Cancer: An Immunohistochemical Study.

Authors:  Iman Seleit; Ola Ahmed Bakry; Dalia Rifaat Al-Sharaky; Rania Abdel Aziz Ragab; Shimaa Ahmed Al-Shiemy
Journal:  J Clin Diagn Res       Date:  2017-06-01

Review 8.  Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism.

Authors:  Dania C Liemburg-Apers; Peter H G M Willems; Werner J H Koopman; Sander Grefte
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

9.  Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-κB-dependent GLUT3 expression.

Authors:  M Watanabe; N Abe; Y Oshikiri; E J Stanbridge; T Kitagawa
Journal:  Oncogenesis       Date:  2012-07-09       Impact factor: 7.485

10.  Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.

Authors:  Paola Parente; Antonella Coli; Guido Massi; Antonella Mangoni; Manuela M Fabrizi; Giulio Bigotti
Journal:  J Exp Clin Cancer Res       Date:  2008-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.